Skip to main content

UBS Group AG

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in ARWR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$70,222,494
-$13,561,696 QoQ
Shares Held
861,520
-35.5% QoQ
Ownership
0.610%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#29
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 76% Shared 0% None 24%

Common Shares in ARWR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ARWR ranks #31 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ARWR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $70,222,494 861,520
2026-03-31 $83,784,190 1,336,271
2025-12-31 $65,545,982 987,287
2025-09-30 $31,668,130 918,183
2025-06-30 $25,289,416 1,600,596
2025-03-31 $20,722,410 1,626,563
2024-12-31 $24,540,183 1,305,329
2024-09-30 $8,552,065 441,511
2024-06-30 $9,052,418 348,304
2024-03-31 $12,896,339 450,921
2023-12-31 $15,562,731 508,586
2023-09-30 $9,931,205 369,602
2023-06-30 $11,802,389 330,970
2023-03-31 $7,603,286 299,342
2022-12-31 $12,480,717 307,710
2022-09-30 $3,422,194 103,546
2022-06-30 $3,211,750 91,217
2022-03-31 $7,327,401 159,326
2021-12-31 $10,277,560 155,016
2021-09-30 $8,115,899 130,000
2021-06-30 $5,980,680 72,213
2021-03-31 $4,770,407 71,941
2020-12-31 $886,615 11,555
2020-09-30 $1,426,922 33,138
2020-06-30 $337,054 7,804
2020-03-31 $346,764 12,053